Biocon reported a consolidated net profit of ₹660 Crore for the December quarter of the current fiscal year, marking a significant improvement from the net loss of ₹42 Crore in the same period the previous year.
The company’s revenue from operations experienced robust growth, increasing by 34.4% to ₹3,953.7 Crore compared to the previous year.
Earnings before interest, taxes, depreciation, and amortisation (EBITDA) rose to ₹926 Crore, up from ₹644.3 Crore in the corresponding period last year. The EBITDA margin increased to 23.4 % from 21.9%.
Biocon Biologics proactively prepaid approximately $200 million to reduce acquisition-related debt during the quarter.
Other income for Q3FY24 included a gain of ₹456 Crore, primarily from the fair valuation of Biocon’s holding in Bicara Therapeutics, resulting from Bicara’s Series C financing. Exceptional items in Q3 FY24 amounted to a net gain of ₹21 Crore, with exceptional gains after tax and minority interest totaling ₹16 Crore.
Net R&D investments for the quarter stood at ₹329 Crore, representing 11% of revenue exSyngene.
Despite pricing pressure in the API business affecting customer offtake, Biocon witnessed sequential revenue growth during the quarter, driven by higher API sales. The subdued year-on-year performance was partially offset by sustained growth across most Generic Formulation products.
Biocon Biologics achieved a remarkable YoY growth of 65 % for Q3FY24, with revenue reaching ₹2,483 Crore.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.